Depressive Disorders - France | Statista Market Forecast

Revenue in the Depressive Disorders market is projected to reach US$813.80m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.67%, resulting in a market volume of US$841.50m by 2029.
In global comparison, most revenue will be generated United States (US$6.26bn in 2024).
In relation to total population figures, per person revenues of US$233.20 are generated in 2024.

Depressive disorders are a common type of mental illness. Symptoms include depressive moods such as feeling sad, low concentration, low self-worth, loss of interest in activities, and, in some cases, thoughts of suicide. Common treatments for depressive disorders include psychological treatments such as psychotherapy, behavioral therapy, and antidepressant medication.

The Depressive Disorders market in the Mental Health market represents the market for antidepressant drug sales. Different types of antidepressants are usually prescribed for the treatment of mild to serious cases of depression, e.g., selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitor (SNRIs), serotonin modulators, as well as tricyclic and tetracyclic antidepressants.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Novartis AG, Pfizer, Bristol-Myers Squibb, GlaxoSmithKline, Patheon Inc, and Sandoz Inc.

Antidepressant drugs
Selective serotonin reuptake inhibitors (SSRIs)
Serotonin norepinephrine reuptake inhibitor (SNRIs)
Serotonin modulators
Tricyclic and tetracyclic antidepressants

Psychotherapy
Mood stabilizers
Anti-anxiety and stimulant medications
Behavioral therapy

The Depressive Disorders market in France is experiencing significant growth and development due to various factors.

Customer preferences: Customers in France are increasingly seeking effective and accessible treatments for depressive disorders. The stigma surrounding mental health issues has reduced in recent years, leading to a greater willingness among individuals to seek help and treatment. As a result, there is a growing demand for pharmaceutical products and therapies that can effectively manage depressive disorders. Customers are also showing a preference for personalized treatment options that take into account their specific needs and symptoms.

Trends in the market: One of the key trends in the Depressive Disorders market in France is the increasing use of digital health solutions. Mobile applications and online platforms that offer mental health support and therapy are gaining popularity among individuals seeking treatment for depressive disorders. These digital solutions provide convenience, anonymity, and accessibility, making it easier for individuals to access support and treatment from the comfort of their homes. Additionally, the use of artificial intelligence and machine learning algorithms in the development of personalized treatment plans is another emerging trend in the market.Another trend in the market is the growing focus on holistic approaches to treating depressive disorders. There is a recognition that mental health is influenced by various factors, including lifestyle, diet, and social support. As a result, there is an increasing demand for complementary therapies such as mindfulness, yoga, and meditation, which are believed to have a positive impact on mental well-being. This trend is driving the development of new products and services that cater to the holistic needs of individuals with depressive disorders.

Local special circumstances: France has a well-established healthcare system that provides universal coverage and access to mental health services. This has played a significant role in driving the growth of the Depressive Disorders market in the country. The government has also implemented initiatives to reduce the stigma surrounding mental health and improve access to care, further supporting the market development.

Underlying macroeconomic factors: The economic stability and high disposable income levels in France have contributed to the growth of the Depressive Disorders market. Individuals are more willing and able to spend on healthcare and wellness products and services. Additionally, the aging population in France is also a key factor driving market growth, as older individuals are more likely to experience depressive disorders and seek treatment.In conclusion, the Depressive Disorders market in France is experiencing growth and development due to changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. The increasing demand for accessible and effective treatments, the use of digital health solutions, the focus on holistic approaches, and the supportive healthcare system in France are all contributing to the market's expansion.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.